Improved bone health behavior using community pharmacists as educators: The Geisinger Health System Community Pharmacist Osteoporosis Education Program

Disease Management and Health Outcomes

Volumn 9, Issue 6, 2001, Pages 329-335

  Newman, E D ^a   Hanus, P ^b  

^a GEISINGER MEDICAL CENTER   (United States)

^b CHA Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE DENSITY; BONE METABOLISM; HEALTH BEHAVIOR; HEALTH CARE DELIVERY; HEALTH PROGRAM; HEALTH PROMOTION; HIGH RISK POPULATION; MONITORING; OSTEOPOROSIS; PATIENT EDUCATION; PATIENT SELECTION; PHARMACIST; PRACTICE GUIDELINE;

EID: 0034969540     PISSN: 11738790     EISSN: None     Source Type: Journal    
DOI: 10.2165/00115677-200109060-00004     Document Type: Article

References (16)

1. Osteoporosis: Frequency, consequences, and risk factors
2. Consensus development statement: Who are candidates for prevention and treatment for osteoporosis?
3. Osteoporosis disease management: Best practices from the Penn State Geisinger Health System
4. Development and validation of a simple questionnaire to facilitate identification of women likely to have low bone density
5. Consensus development statement. Who are candidates for prevention and treatment for osteoporosis?
6. ASHP statement on the pharmacist's role in primary care
7. Implementing disease management in community pharmacy practice
8. Improving outcomes of community-dwelling older patients with diabetes through pharmacist counseling
9. Asthma patients' satisfaction with the frequency and content of pharmacy counseling
10. How can we reduce the burden of osteoporosis?
11. Fracture risk reduction with alendronate in women with osteoporosis: The fracture intervention trial
12. Risedronate reduces hip fracture in patients with low femoral neck bone mineral density
13. Can we prevent fractures?